Navigation Links
NIAID scientists to speak on range of infectious disease topics at major scientific meeting
Date:10/22/2008

Anthony S. Fauci, M.D., will speak during the opening session of ICAAC/IDSA 2008, a joint meeting of the American Society for Microbiology and the Infectious Diseases Society of America, in Washington, DC. His keynote lecture at 4:30 p.m. on Saturday, Oct. 25, is titled Global Health and Infectious Diseases: A Look to the Future. Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Among many global health challenges, infectious diseases remain among the most problematic, accounting for about one quarter of all deaths globally, and nearly two-thirds of deaths in sub-Saharan Africa. Dr. Fauci will discuss progress--and remaining challenges--in the fight against major infectious causes of death and disability such as HIV/AIDS, malaria, tuberculosis and drug-resistant microbes. He also will discuss how conceptual and technological progress in fields such as genomics and nanotechnology has invigorated infectious disease research. These advances also are contributing to exciting studies on the ecology of human disease, including the Human Microbiome Project, which is exploring how the billions of bacteria that inhabit our bodies contribute to health and illness.

Other NIAID scientists are scheduled to present findings during the four-day meeting as well. The range of topics covered reflects the broad scope of NIAID's research efforts aimed at better understanding, treating and preventing infectious and immune-mediated diseases.

  • Noroviruses, the highly contagious viruses that cause the episodes of acute gastroenteritis also known as winter vomiting disease (Kim Green, Ph.D.)
  • The role of gut-dwelling commensal bacteria in producing the symptoms of Crohn's disease, a chronic inflammatory disease of the intestines (Warren Strober, M.D.)
  • Antibiotic-resistant bacterial infections caused by Staphylococcus epidermidis (Michael Otto, Ph.D.) and Staphylococcus aureus (Frank DeLeo, Ph.D.)
  • Finding ways to treat primary immunodeficiencies, inherited conditions in which immune function is impaired (Steve Holland, M.D.)
  • Containing Ebola virus, for which there is currently no vaccine or specific treatment (Gary Nabel, M.D., Ph.D.)


'/>"/>

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related biology news :

1. NIAID funds studies of how SARS and bird flu evade antiviral responses
2. NIAID announces 25 new awards to develop radiation countermeasures
3. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
4. NIAID announces grants to stimulate food allergy research
5. British scientists go cloud-hopping in the Pacific to improve climate predictions
6. Scientists map soils on an extinct American volcano
7. Scientists call for protected swimways for the endangered leatherback sea turtle
8. Scientists from Granada find a potential treatment to prevent diabetes and obesity
9. Scientists discover bacteria that can cause bone infections
10. Scientists propose the creation of a new type of seed bank
11. EMBO honors 59 leading life scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 /PRNewswire/ ... of genomic services and solutions with cutting edge next-generation ... has completed a USD $75 Million [515 Million RMB] ... CMB International Capital Management ( Shenzhen ) ... Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment Center ...
Breaking Biology Technology: